Hematologic Malignancies Testing Market Industry Analysis, Size, Share and Forecast 2021 – 2027
Based on the in-depth analysis the research also brings to light major facts pertaining to the vital aspects such as market share, size, and growth rate. Deep dive into other aspects including the investment feasibility, demand and supply, import and export status, supply chain management and growth prospects narrates a lot about what the business environment will be like for the forecast period,2020 - 2027. All the vital statistics in the report are explained with the help of resources such as tables, charts, and info graphics.
The global Hematologic Malignancies Testing Market is forecasted to be worth USD 5.45 Billion by 2027, according to a current analysis by Emergen Research. The rapid growth of the global market for Hematologic Malignancies Testing can be attributed to the rising prevalence of Leukemia and Multiple myeloma. 10% of all hematologic cancers are due to multiple myeloma. It is estimated that about 12,830 deaths from multiple myeloma (7,190 in men and 5,640 in women) will happen in 2020.
Besides, increasing awareness among patients and healthcare professionals about the initial diagnosis of Hematologic Malignancies is anticipated to stimulate growth over the forecasted timeframe. Furthermore, the rising emphasis on personalized medicine is also expected to drive the market growth of global Hematologic Malignancies Testing. This procedure can be used in a very particular way to identify and diagnose disorders, classifying those through hereditary variance instead of by symptoms. This encourages more precise and efficient therapies, strengthening the prognosis of patients.
Key Highlights From The Report
In March 2020, Sysmex Corporation received japan marketing clearance for BGI Genomics Coronavirus kit distribution. This initiative will strengthen its position in Japan.
During the forecast timeline, the Next-generation sequencing segment will hold the largest market with a CAGR of 14.8%. In next-generation sequencing, the steadily developing cohort of technologies allowing the detection of gene variations present in Rna and DNA. In the case of hematologic malignancies, such differences provide diagnostic relevance.
It is expected that the Leukemia segment will hold the largest market throughout the forecasted period. The demand for early diagnosis and growing the cases of leukemia are expected to drive the growth of this segment.
The region of North America accounts for the largest market in the forecast timeline. The presence of the key players, and the existing advanced healthcare facilities, are the forces responsible for growth.
Key participants include ArcherDx, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, Invitae Corporation, NeoGenomics Laboratories, Inc., Abbott Laboratories, Cancer Genetics Inc., Adaptive Biotechnologies Corporation, Asuragen, Inc., and Invivoscribe, Inc. among others.
Request For Free Sample@
Product Outlook (Revenue, USD Billion; 2017-2027)
Technology Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction
Fluorescence in situ hybridization
Disease Outlook (Revenue, USD Billion; 2017-2027)
End-Use Outlook (Revenue, USD Billion; 2017-2027)
Regional Outlook (Revenue, USD Billion; 2017-2027)
Table of Content
Chapter 1. Methodology & Sources
1.1. Hematologic Malignancies Testing Market Definition
1.2. Hematologic Malignancies Testing Market Research Scope
1.3. Hematologic Malignancies Testing Market Methodology
1.4. Hematologic Malignancies Testing Market Research Sources
1.4.3. Paid Sources
1.5. Hematologic Malignancies Testing Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Hematologic Malignancies Testing Market Segmentation & Impact Analysis
Find similar reports by Emergen Research
Medical Supplies Market By Type, By Application (Urology, Wound Care, Radiology, Respiratory, Infection Control, Cardiology, IVD, Other Applications), By End User (Hospitals, Clinics, Others), and By Region, Forecasts to 2027
Cloud Billing Market By Component (Solution Services), By Billing Type, By Deployment Type (Private, Public), By Service Model (IaaS, PaaS, SaaS), By Organization Size (Large Enterprises, Small and Medium-Sized Enterprise), By Vertical, and By Region, Forecasts to 2027
Nanopharmaceutical Drugs Market By Type, By Application, By Distribution Channel, Forecasts to 2027
Clinical Perinatal Software Market By Product Type, By Deployment Mode, By Application, By End-User, Forecasts to 2027
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee
You have no groups that fit your search